Results 21 to 30 of about 42,868 (258)

Effect of Immunotherapy and Stereotactic Body Radiation Therapy Sequencing on Local Control and Survival in Patients With Spine Metastases

Advances in Radiation Oncology, 2023
Purpose: Stereotactic body radiation therapy (SBRT) is commonly used to treat spinal metastases in combination with immunotherapy (IT). The optimal sequencing of these modalities is unclear.
Jacob Eckstein, MD, Emile Gogineni, DO, Baho Sidiqi, MD, Noah Lisser, BS, Bhupesh Parashar, MD, DrPH   +4 more
doaj   +1 more source

Interobserver Reliability in Describing Radiographic Lung Changes After Stereotactic Body Radiation Therapy [PDF]

, 2018
Purpose Radiographic lung changes after stereotactic body radiation therapy (SBRT) vary widely between patients. Standardized descriptions of acute (≤6 months after treatment) and late (\u3e6 months after treatment) benign lung changes have been proposed
Hugo, Geoffrey D., Jan, Nuzhat, Kahn, Jenna M., Kalman, Noah S., Mahon, Rebecca N., Weiss, Elisabeth, Zhao, Sherry S.   +6 more
core   +3 more sources

First-Line Anlotinib Combined with Stereotactic Body Radiation Therapy for an Octogenarian with Pulmonary Carcinosarcoma

Cancer Management and Research, 2022
Long Liang,1,* Taiyu Chen,2,* Tao Ren,3 Mian Mao,4 Keli Wang,5 Chunhan Tang,2 Juan Xiao,1 Hongyuan Jia,1 Wenli Chen,1 Qifeng Wang,1 Tao Li1 1Department of Radiation Oncology, Sichuan Cancer Hospital and Institution, Sichuan Cancer Center, School ...
Liang L, Chen T, Ren T, Mao M, Wang K, Tang C, Xiao J, Jia H, Chen W, Wang Q, Li T   +10 more
doaj  

Survival After Combining Stereotactic Body Radiation Therapy and Tyrosine Kinase Inhibitors in Patients With Metastatic Renal Cell Carcinoma

Frontiers in Oncology, 2021
BackgroundStereotactic body radiation therapy (SBRT) and tyrosine kinase inhibitors (TKIs) are effective treatments for metastatic renal cell carcinoma, but data on combining these two modalities are scarce.
Yang Liu, Zhiling Zhang, Hui Han, Shengjie Guo, Zhuowei Liu, Mengzhong Liu, Fangjian Zhou, Pei Dong, Liru He   +8 more
doaj   +1 more source

Re-Irradiation With Stereotactic Body Radiotherapy for In-Field Recurrence of Pancreatic Cancer After Prior Stereotactic Body Radiotherapy: Analysis of 24 Consecutive Cases

Frontiers in Oncology, 2021
Purpose/ObjectivesLocally recurrent pancreatic cancer is a therapeutic challenge, and aggressive approaches are needed to improve its clinical outcomes.
Yuxin Shen, Xiaofei Zhu, Fei Cao, Hongliang Xie, Xiaoping Ju, Yangsen Cao, Shuiwang Qing, Zhen Jia, Lei Gu, Fang Fang, Huojun Zhang   +10 more
doaj   +1 more source

Stereotactic Magnetic Resonance-guided Online Adaptive Radiotherapy for Oligometastatic Breast Cancer: A Case Report. [PDF]

, 2018
We present a case of durable local control achieved in a patient treated with stereotactic magnetic resonance-guided adaptive radiation therapy (SMART) for an abdominal lymph node in the setting of oligometastatic breast cancer.
Cao, Minsong, Dang, Audrey, Lamb, James, Lee, Percy, Low, Daniel A, Raldow, Ann C, Steinberg, Michael L, Tyran, Marguerite   +7 more
core   +1 more source

The short-term outcomes of pulmonary metastasectomy or stereotactic body radiation therapy for pulmonary metastasis from epithelial tumors

Journal of Cardiothoracic Surgery, 2020
Background Stereotactic body radiation therapy (SBRT) has recently been widely performed for relatively small-volume tumors. We analyzed the short-term outcomes of pulmonary metastasectomy (PM) or SBRT for pulmonary metastases.
Ryu Kanzaki, Osamu Suzuki, Takashi Kanou, Naoko Ose, Soichiro Funaki, Yasushi Shintani, Masato Minami, Keisuke Tamari, Keisuke Otani, Yuji Seo, Fumiaki Isohashi, Kazuhiko Ogawa, Meinoshin Okumura   +12 more
doaj   +1 more source

Plasma metabolomic profiles in liver cancer patients following stereotactic body radiotherapy

EBioMedicine, 2020
Background: Stereotactic body radiotherapy (SBRT) is an effective treatment for hepatocellular carcinoma (HCC). This study sought to identify differentially expressed plasma metabolites in HCC patients at baseline and early during SBRT, and to explore if
Sylvia S.W. Ng, Gun Ho Jang, Irwin J. Kurland, Yunping Qiu, Chandan Guha, Laura A. Dawson   +5 more
doaj   +1 more source

Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio in Hepatocellular Carcinoma Treated with Stereotactic Body Radiotherapy

The Korean Journal of Gastroenterology, 2022
Purpose: To investigate the prognostic value of the neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) in patients with hepatocellular carcinoma (HCC) treated with stereotactic body radiotherapy (SBRT).
Younghee Park, Ah Ram Chang
doaj   +1 more source

Dosimetric study for spine stereotactic body radiation therapy: magnetic resonance guided linear accelerator versus volumetric modulated arc therapy

Radiology and Oncology, 2019
Stereotactic body radiation therapy (SBRT) given in 1-5 fractions is an effective treatment for vertebral metastases. Real-time magnetic resonance-guided radiotherapy (MRgRT) improves soft tissue contrast, which translates into accurate delivery of spine
Yadav Poonam, Musunuru Hima B., Witt Jacob S., Bassetti Michael, Bayouth John, Baschnagel Andrew M.   +5 more
doaj   +1 more source